Keros Therapeutics | 4:持股變動聲明-董事 GORDON CARL L
Keros Therapeutics | 4:持股變動聲明-董事 ORBIMED ADVISORS LLC
Keros Therapeutics | 4:持股變動聲明-董事 BIENAIME JEAN JACQUES
Keros Therapeutics | 3:首次持股聲明-董事 BIENAIME JEAN JACQUES
Keros Therapeutics | 4:持股變動聲明-董事 GORDON CARL L
Keros Therapeutics | 4:持股變動聲明-董事 GRAY MARY ANN
Keros Therapeutics | 4:持股變動聲明-董事 Knowles Julius
Keros Therapeutics | 4:持股變動聲明-董事 Nussbaum Ran
Keros Therapeutics | 4:持股變動聲明-董事 Kariv Tomer
Keros Therapeutics | 4:持股變動聲明-董事 Seth Alpna
Keros Therapeutics | 4:持股變動聲明-董事 Farzan Nima
Keros Therapeutics | 4:持股變動聲明-高管 Seehra Jasbir
Keros Therapeutics | 4:持股變動聲明-高管 Seehra Jasbir
Keros Therapeutics | 4:持股變動聲明-高管 Regnante Keith
Keros Therapeutics | 4:持股變動聲明-高管 Rovaldi Christopher
Keros Therapeutics | 4:持股變動聲明-高管 Cooper Simon Peter
Keros Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Alkeon Capital Management, LLC(5.0%),Panayotis D. Sparaggis(5.0%)
Keros Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-FMR LLC(12.931%),Abigail P. Johnson(12.931%)
Keros Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-BlackRock, Inc.(6.8%)
Keros Therapeutics | 4:持股變動聲明-高管 Regnante Keith
暫無數據